Bleomycin in Hodgkin's lymphoma – A boon or a bane? – A retrospective study of bleomycin pulmonary toxicity in Hodgkin's lymphoma

Figures

• 

  Figure 1. HRCT chest with bleomycin pulmonary toxicity showing multiple nodular ground glass areas diffusely involving both the lungs representing mild and early changes of lung injury

• 

  Figure 2. HRCT showing classical appearance of lung toxicity as extensive diffuse alveolar damage in bilateral lungs seen as a) Diffuse ground glass opacities and b) Ground glass opacity and areas of basal consolidation c) NSIP pattern

• 

  Figure 3. HRCT changes representing sequel of bleomycin toxicity, a) Fibrotic type of NSIP b) DAD with bronchiectasis and septal thickening c) UIP pattern

• 

  Figure 4. Chest X-ray showing nodular and patchy opacities predominantly in lower zones